Oslo Cancer Cluster aims to be one of the world leading cancer
clusters by 2013 and they have currently more than 60 members. The
main focus of Oslo Cancer Cluster is local collaboration, international
partnership and increasing the funding and accessible capital for their
members. They also focus on establishing an eicient international
clinical trials network as well as creating the Oslo Cancer Cluster
Innovation Park which will bridge research, biopharma and education.
With this membership Birk Venture will have an excellent opportunity
to further participate in the development of new cancer diagnostics
and medicines.
